Picture representing current thematic area

Disclosure Logs

2014

ATI 288 Request for information relating to the number of female and male researchers VMD employ
ATI 287 Request for information relating to office accommodation our organisation provides to staff to carry out trade union business
ATI 286 Request for information relating to phenylbutazone found in meat from horses slaughtered in the UK in 2013
ATI 285 Request for information relating to relating to alleged errors and poor procedures around the supply of medicated feedstuffs to farmers
ATI 284 Request for information relating to relating to alleged errors and poor procedures around the supply of medicated feedstuffs to farmers
ATI 283 Request for information relating to relating to alleged errors and poor procedures around the supply of medicated feedstuffs to farmers
ATI 282 Request for certain information relating to medicines prescribed using the "Special Exemption" procedure
 

2013

ATI 281 Request for information relating to the yearly supply of the vaccine Glanvac over the last 5 years to the UK under the VMD special license
ATI 280 Request for information relating to Poultry contaminated with MRSA
ATI 279 Request for information on the amount of Glanvac that has been imported into the uk in the last 5 years
ATI 278 Request for information relating to adverse reactions: Bob Martin Spot On products and flea collars for cats
ATI 277 Request for information on all adverse reactions that have been reported to the VMD regarding 'Bob Martin Cat and Kitten Spot On Flea Treatment Products - All of its Product Range Including Flea Collars'
ATI 276 Request for information regarding records of research misconduct at VMD
ATI 275 Request relating to the company Solvay Chimie SA
ATI 274 Request for the Assessment Reports for the most recent GMP Inspection of Hydrokem Aerosols
ATI 273 Request for a wide range of information relating to the VMD’s purchase of food related products
ATI 272 Request for a wide range of information relating to the VMD’s IT spend
ATI 271 Request for information relating to Noroseal 2.6 g Intramammary Suspension for Cattle (Vm 02000/4361)
ATI 270 Request for information relating to the environmental fate and effect data we hold regarding the following substances: Ampicilin, Levamisole and Deltamethrin (including marine fate & species)
ATI 269 Request for Information relating to the Export Certificate Scheme, Special Import Certificates, Special Treatment Certificates, about holders of current holders of Wholesaler Dealer Import Certificates and most dispensed products
ATI 268 Request for information on LAN/WLAN contracts
ATI 267 Request for information relating to the seizure and destruction of veterinary products on a private plane which landed at Stansted on May 3 2013
ATI 266 Request for information relating to specific ICT contract(s) for Storage Hardware Maintenance and Storage Virtualisation Software
ATI 265 Request for data on amoxicillin/doxycycline Phase II environmental fate and aquatic/terrestrial toxicity studies
ATI 264 Request for the statistics clarifying the number of adverse reactions pertaining to Permethrin related products on the market
ATI 263 Request relating to the VMD's Wi-Fi
ATI 262 Request for information relating to the evidence that Boehringer has provided for the efficacy of Prascend in treating the clinical signs of PPID/Cushings disease in horses with particular regard to laminitis (following up on ATI261)
ATI 261 Request for information relating to the evidence that Boehringer has provided for the efficacy of Prascend in treating the clinical signs of PPID/Cushings disease in horses with particular regard to laminitis
ATI 260 Request for environmental risk assessment for Tylan 200
ATI 259 Request for environmental risk assessment for Tylan 200
ATI 258 Request for environmental risk assessments for Tylan & Bilosin
ATI 257 Request for information regarding the number of botulism vaccine doses used in Northern Ireland
ATI 256 Request for information regarding the number of botulism vaccine doses used in Northern Ireland
ATI 255 Request for information regarding the importing of Sungate into the UK
ATI 254 Request for information regarding the inspection of Bushu Pharmaceuticals in Kawagoe, Saitama, Japan
ATI 253 Request for SARRS data held by the Veterinary Medicines Directorate
ATI 252 Request for information regarding Special Import Certificates
ATI 251 Request regarding information relating to Fixed Telecommunications and Internet Services
ATI 250 Request for details regarding each horse carcass destined for human consumption that tested postive for Phenylbutazone
ATI 249 Request regarding information sent to Defra Ministers or officials warning of Phenylbutazone in horse carcasses
ATI 248 Request for information regarding correspondence relating to Phenylbutazone in horse carcasses
ATI 247 Request for information regarding the sterility of Release 300 mg/ml soltion for injection
ATI 246 Request for information regarding phenylbutazone contaminated horses believed to have entered the human food chain
ATI 245 Request for enviromental risk assessments for Colfen & Fenflor
ATI 244 Request for information regarding all import licenses for Douvistome
ATI 243 Request for information relating to the use of organophosphate dips
ATI 242 Request for information relating to a racehorse found to be contaminated with a medicine that was slaughtered for human consumption
ATI 241 Request for information regarding the VMDs mobile phone and telephone maintenance contracts
ATI 240 Request for information relating to phenylbutazone in horse meat
ATI 239 Request for information relating to ATC applications for products containing dicyclanil
ATI 238 Request for information relating to reported Adverse Drug Reactions in animals
ATI 237 Request for information regarding the use of Formalin on Scottish salmon farms
ATI 236 Request for certain information in relation to our HR and payroll 'solution/service'
 

2012

ATI 235 Request for information regarding the UK veterinary pharmaceutical market
ATI 234 Request for information regarding the approval of a number of veterinary medicinal products
ATI 233 Request for list of wholesale distributors of flea & tick control products
ATI 232 Request for information on the illegal use of Ivermectin/Emamectin
ATI 231 Request for information to establish set of realistic properties regarding the environmental fate of the certain chemicals
ATI 230 Request for efficacy information relating to Mixed Vegetable & Garlic and Fenugreek Tablets for dogs and cats
ATI 229 Request for information relating to adverse effects of Ovarid & Delvosterone
ATI 228 Request for information relating to Data Protection Act incidents
ATI 227 Request withdrawn
ATI 226 Request withdrawn
ATI 225 Request for information relating to adverse reactions to Metacam
ATI 224 Request for information relating to Salartect, Paramove & Samaki SLT
ATI 223 Request for supplier lists to the VMD
ATI 222 Request withdrawn
ATI 221 Request for information relating to R&D Competition 2012/2013
ATI 220 Request for list of drugs reported under Suspected Adverse Reaction
ATI 219 Request for information relating to the Veterinary Medicines Directorate’s bonus payments
ATI 218 Request for information about the VMD's use of the Regulation of Investigatory Powers Act 2000 (RIPA) and the Regulation of Investigatory Powers Act 2000 Scotland (RIPSA)
ATI 217 Follow-up request to ATI 210 below
ATI 216 Request for information relating to feline veterinary medicines by injection
ATI 215 Request seeking ICT Contracts Update
ATI 214 Request for information relating to Calmex
ATI 213 Follow up to ATI 206 request for information relating to Metacam
ATI 212 Request for information relating to reported failures of parvovirus vaccine
ATI 211 Request for details of any currently valid market authorisations for Hydrogen Peroxide based products for use in treating salmon for sea lice infestations
ATI 210 Request for information relating to recruitment contracts
ATI 209 Request for certain information relating to an inspection report
ATI 208 Request for details of the use of powers of entry by the Veterinary Medicines Directorate (VMD) under any of the relevant Acts or items of secondary legislation during the period 2008 - 2011, excluding Trading Standards investigations.
ATI 207 Environmental Information Regulations request for environmental information on Nitroxynil

2011

ATI 206 Request for information relating to Metacam
ATI 205 Request for information contained in or relating to the EPAR for Cardisure
ATI 204 Request for end-point data are held by VMD on toxicity of florfenicol on terrestrial organisms
ATI 203 Wide ranging request relating to egg testing under the VMD's statutory residues surveillance scheme
ATI 202 Wide ranging request relating to ICT
ATI 201 Request for the total electrical load of IT equipment used to process the VMD's data
ATI 200 Request relating to Trade Union funding and staff time - Defra replied covering the core Department and its Agencies
ATI 199 Request for information about a Novartis product: Vetrazin.
ATI 198 Request for all ICT Contracts and other specified information relating to mobiles phones and PBX Maintenance.
ATI 197 Request for information about the full monetary value of the Analytical Testing contract for the 2011 & 2012 GB National Residues Control Plan (excluding honey and Northern Ireland samples).
ATI 196 Request for information about flukicide triclabendazole - in particular whether it is excreted in faeces and whether it has any insecticidal effects.
ATI 195 Request for information about the use of Government Procurement Cards.
ATI 194 Request for information relating to ICT.
ATI 193 Request for information on excipients used in injectable formulations, particularly Ivomec Classic Injection for Cattle and Sheep (Ivermectin)
ATI 192 Request for information about the UK Government's online services.
ATI 191 Request withdrawn by applicant.
ATI 190 Request for information about ecotoxic effects of veterinary medicines given to cows - ecotoxicity data about closantel.
ATI 189 Request for reports/assessments/analyses and communications relating to use of antibiotics in agriculture and implications for human health.
ATI 188 Request for 5 unpublished genotoxicity study reports and 1 unpublished review of genotoxicity commissioned by CEVA reports relating to fumagillin dicyclohexylamine.
ATI 187 Request for information relating to the nature and cost of the payments processing that the VMD undertake.
ATI 186 Request for information relating to how many veterinary pharmaceutical companies are licensed under the VMD & how much aggregate revenue did they accrue in a recent year? (2009? 2008?).
ATI 185 Request for information for each of the SPECIAL IMPORT CERTIFICATES (SIC) issued in the 2010 calendar year: a) Name of product, b) product authorisation number and country of origin, and c) number of animals treated.
ATI 184 Request for information about a number of Defra pilot studies.
ATI 183 Request for information relating to ICT.
ATI 182 Request for information relating to suspected adverse reaction reports involving feline vaccines.
ATI 181 Request for information relating to the average monthly number of prescriptions items prescribed by Veterinary practice in England for 2010, with the practice name and county.
ATI 180 Request for information relating to Copinox Ewe/Calf 4g Capsule.

2010

ATI No. Subject
ATI 179 Request for information on the total number of the Veterinary Medicines Directorate employees at the end of financial year 2009-10 and the total spent on Veterinary Medicines Directorate employees during financial year 2009-10.
ATI 178 Request for information since 12th May 2010 relating to the Coalition Government's Comprehensive Spending Review and the Coalition Government's Public Bodies Review.
ATI 177 Request for information about voluntary redundancies.
ATI 176 Request for information about additional statistics on veterinary antimicrobial use: veterinary usage in kgs of third and fourth generation cephalosporins in 2009; and veterinary usage in kgs of lincomycin in 2009.
ATI 175 Request if an Animal Testing Certificate (ATC) was applied for and granted for an attached study relating to the product: Zactran (Gamithromycin). Information requested related to:
  • The existence of an application for an ATC;
  • the data provided by the individuals requesting the ATC;
  • confirmation that ATC has been granted, or confirmation that ATC has been refused;
  • disclosure of VMD assessment of ATC application;
  • disclosure of any advice given by VMD during trial;
  • disclosure of Adverse Drug Reactions from the study;
  • disclosure of clinical trials data after grant of.
ATI 174 Request for wide range of corporate information including copy of VMD briefing to new Minister.
ATI 173 Request for correspondence relating to the handling of earlier request (ATI 159). Most information provided. VMD provided ICO with documents on case in late December. VMD awaiting results of ICO review.
ATI 172 Request for information about the total amount of money spent by the VMD supporting environmentalist groups in 2009/10.
ATI 171 Request whether VMD hold market authorisations for the following veterinary medicinal products:
  • Calciject 20 CM Solution for injection VM No. 02000/4120 Date of issue 15/11/1994
  • Calciject 20 CM solution for injection 02000/4189 Date of issue 23/05/2000
  • Calciject 40 CM solution for injection 02000/4125 Date of issue 05/07/1994
  • Calciject 40 solution for injection 02000/4069 Date of issue 19/03/1986
  • Calciject LV solution for injection VM 02000/4124 Date of issue 20/12/1994
  • Pen & Strep suspension for injection Vm No. 02000/4100 Date of issue 12/03/1991
  • Magniject 25% w/v solution for injection Vm No. 02000/4129 Date of issue 19/10/1994
  • Norocillin 30% w/w suspension for injection Vm No. 02000/4099 Date of issue 20/04/1998
  • Norocillin LA suspension for injection VM No. 02000/4057 Date of issue 04/04/1985
And, in each case, that part of the market authorisation which specifies the method of batch-testing quality control, in particular whether the rabbit pyrogen test, the bacterial endotoxin test or another test is specified. If you do not hold the market authorisation but hold the batch-testing quality control information, please let us have that in any event.
ATI 170 Request for information relating to staff numbers and HR/payroll services.
ATI 169 Request for information relating to staff in Communications and Procurement.
ATI 168 Request for information relating to staff in Finance, Procurement and ICT.
ATI 167 Request for details of Marketing Authorisation for three products for treating salmon with sea lice using hydrogen peroxide.   The products are Salartect registered by Brenntag, and Paramove and Samaki SLT registered by Interox Solvay. Copies of approvals, MSDS sheets, label instructions and details on methods of application.
ATI 166 Subject access request under DPA.
ATI 165 Request for further information on Epiphen.
ATI 164 Request for information about the total amount of money paid to trade unions by Veterinary Medicines Directorate and the amount of staff time spent on union activities by Veterinary Medicines Directorate employees.
ATI 163 Request to disclose the inspection report on the Bush House Veterinary Group. Request refused: Upheld on Internal Review. Requestor appealed to ICO. Requestor withdrew complaint following provisional view from ICO.
ATI 162 Request for documentation on the Gateway 5 review of the 2005 VMD contract with the LGC for analytical services (RMP2260).
ATI 161 Request for copies of the bioequivalence test data/reporting associated with/undertaken for Epiphen.
ATI 160 Request withdrawn by applicant.
ATI 159 Request for information concerning sea lice treatments used in salmon farms in Scotland. Most information provided after internal review. Requestor appealed to ICO. VMD provided ICO with documents on case in late December. VMD awaiting results of ICO review.
ATI 158 Request for a copy of the hospitality and gift register for each of the years 2007, 2008 and 2009 inclusive.
ATI 157 Request for information relating to how many cats need veterinary treatment after accidentally being treated by dog flea drops by their owners.
ATI 156 Request for information relating to any person employed by VMD (either as a staff member, a freelancer, a contractor), who was paid over £100,000.
ATI 155 Request for information relating to ICT.
ATI 154 Request for information relating to Flood planning.
ATI 153 Since 1 April 2008, how much the organisation paid to suppliers in interest for late payment pursuant to the Late Payment of Commercial Debts (Interest) Act 1998 and b) the total value of the suppliers' invoices concerned.
ATI 152 Since 8 October 2008 to date, a) how much the organisation paid to suppliers in interest for late payment pursuant to the Late Payment of Commercial Debts (Interest) Act 1998 and b) the total value of the suppliers' invoices concerned.
ATI 151 Since 8 October 2008 to date, a) the number of suppliers who have not been paid within 10 days and b) the total value of the suppliers' invoices concerned.
ATI 150 Since 8 October 2008 to date, the percentage of suppliers' invoices that a) have and b) have not been paid within 10 days.
ATI 149 Request for agency corporate publications
ATI 148 Request for information relating to veterinary lincomycin usage statistics for 2008
ATI 147 Request for all information that VMD hold that is directly or indirectly related to the Norbrook teat seal, created/received on and between the 1 August 2009 and the 21 December 2009.

2009

ATI No. Subject
ATI 146 Request for information relating to staff numbers.
ATI 145 Request for information relating a formulation and its equivalence to that employed for the Virbac Effipro spot-ons.
ATI 144 Request for information relating food procured and Christmas parties hosted by VMD.
ATI 143 Request for information relating to the the VMD's staff contacts.
ATI 142 Request withdrawn by applicant.
ATI 141 Request for information relating product characterization for immunological preparations as well as labeling, field trials and scientific studies - coccidiosis vaccine.
ATI 140 Request for information relating to the VMD's key contacts.
ATI 139 Request withdrawn.
ATI 138 Request for information relating to the VMD's income and staffing.
ATI 137 Request for information relating to the cost of developing, running and managing the VMD website and job descriptions.
ATI 136 Request for information relating total number of STCs/SICs approved in the last 18 months
ATI 135 Request for information relating to research requirements.
ATI 134 Request for information relating to the related to the Norbrook teat seal.
ATI 133 Request for information relating to the Long March product
ATI 132 Request for information relating Information Communication Technology strategy and costs.
ATI 131 Request for information relating to committee structures.
ATI 130 Request for information relating to corporate structure within the VMD and ICT strategy.
ATI 129 Request for all expenses claimed by the chairman and chief executive of your organisation during the financial year 2008-2009; and a list of the travel expenses claimed by the chairman and chief executive, broken down into the following categories: car mileage, taxi/private hire car, rail and air.
ATI 128 Request for information relating to public funding of the VMD, to people seconded to the VMD and jobs advertised.
ATI 127 Request for a list of all events hosted by your organisation, at a cost of £1,000 or greater, and the date, location, details and costs of these events.
ATI 126 Request for information relating to DNA probes.
ATI 125 Request for information relating to Nobilis SG9R.
ATI 124 Request for information relating to the VMD's organisational structure.
ATI 123 Request for information relating to the VMD's use of translation services.
ATI 122 Information relating to key personnel within the VMD.
ATI 121 Information relating to corporate issues within the VMD.
ATI 120 Information relating to corporate issues within the VMD.
ATI 119 Request for veterinary lincomycin usage statistics, going back at least as far as 1998 (or earlier if these are available).
ATI 118 Request for information on the incidence of Suspected Adverse Events (SARs) involving Rimadyl.
ATI 117 Request for information relating to the ecotoxicological data submitted by Merial when Clorsulon was approved for use and the ecotoxicological data for Oxfendazole when given in bolus form, for example as Autoworm First Grazer and Autoworm Finisher.
ATI 116 Request for all correspondence between the Veterinary Residues Committee and food production companies related to testing plans for imported animals.
ATI 115 Request for information in relation to the product: Orbeseal Dry Cow Intramammary Suspension.
ATI 114 Request for information in the Environmental Risk Assessments for the products Fenflor and Shotaflor.

2008

ATI No. Subject
ATI 113 List of all products and amounts for which the VMD has granted permission to import a product for use under a STC or SIC.
ATI 112 Corporate Documents.
ATI 111 Information relating to key personnel.
ATI 110 Hampton Consultation.
ATI 109 Information relating to VMD's contracts for multi function devices, photocopiers and printers.
ATI 108 Information relating to key personnel.
ATI 107 Information relating to Information Communication Technology.
ATI 106 Information in regards to key personnel within our organisation.
ATI 105 Information relating to leases (excluding property).
ATI 104 GMP status and products for the company Diamond Laboratories, also known as Diamond Animal Health, also known as Heska Corporation.
ATI 103 Narrowed down request for information relating to the marketing authorisation for Nobilis SG9R (see ATI0097).
ATI 102 Request to supply the total UK usage of Permethrin and Cypermethrin for 2006.
ATI 101 Request for information on Estates and Facilties Management SLAs.
ATI 100 Request for information on the VMD's Corporate Business.

2007

ATI No. Subject
ATI 099Information on the VMD's ICT systems.
ATI 098Information about the reference product upon which the copy cat license for Kloxerate Plus DC is based.
ATI 097Information relating to the marketing authorisation for Nobilis SG9R.
ATI 096Request for information regarding results of clinical trials performed by Pfizer, which demonstrate the safety and efficacy of Rimadyl.
ATI 095Information about dealings between the VPC and public affairs firms in the last five years.
ATI 094Disposal of antibiotic data.
ATI 093Request relating to VMD's use of video conferencing.
ATI 092Information about Information Communication Technology strategy and costs for the VMD.
ATI 091Number of samples tested for Malachite Green Leucomalachite Green in farmed salmon since 2001, including names of companies.
ATI 090Information relating to the Norbrook v MAFF Judicial Review.
ATI 089A copy of the VMD's IT Strategy and IT staff hierarchy.
ATI 088Information relating to aquatic environmental incidents reported in MAVIS 62.
ATI 087Information relating to horses being given virginiamycin through the STA system.
ATI 086Further information to requests dated 20&21/2 - information as per ATI0081 but up to date.
ATI 085Information related to letter dated 16/1/07 with a copy of any subsequent communications between the VMD and the ACA in relation to Synthetic Pyrethroid (SP) sheep dips.
ATI 084All documentation and information pertaining to Crystal Violet contamination of Chilean farmed salmon.
ATI 083Specific details of contact with the Chilean government and farming industry or any other companies including Findus in relation to positive Crystal Violet sample.
ATI 082Cancelled - incorrectly logged as new ATI but was a request for an internal review of ATI0078
ATI 081Any new information on Crystal Violet to include any contact with the Chilean government or any companies and other stakeholders.
ATI 080All correspondence between manufacturers, NOAH or anyone acting for them, since 1/1/05, concerning synthetic pyrethroid sheep dips.
ATI 079Further information relating to Special Import Certificates
ATI 078Information on Crystal Violet in farmed salmon.
ATI 077Data, including unpublished data, relating to the effect of the administration of avoparcin on salmonella load/shedding in cattle, sheep and pigs.
ATI 076Information relating to Special Import Certificates system.
ATI 075Safety data concerning veterinary medicines containing tetracycline antibiotics as the active ingredient and feed additives containing avoparcin as active ingredient.

2006

ATI No. Subject
ATI 074Information held by the VMD on the origin of permethrin in UK fleeces in 2005.
ATI 073Copies of the draft reports by the CSL into sheep dip run-off studies and the fording of watercourses.
ATI 072Any letters received since the suspension of MAs from the manufacturers of the SP sheep dips concerned or anyone acting on their behalf (relates to ATI0063).
ATI 071Request for further information on representations made to the VMD/VPC by third parties e.g. the ACA.
ATI 070Identities of retailers providing information for the VRC Annual Report.
ATI 069Information submitted as part of the application for an MA for Vivitonin.
ATI 068Information on farmed salmon samples tested as positive for Malachite Green.
ATI 067Detailed information relating to contracts for hardware, software, telephony etc.
ATI 066Further requests in relation to Lelystad (Dutch) tuberculin. Opened as a new ATI as advised by IMD.
ATI 065Request for more detailed information on adverse reactions to flea treatments in which Pyrethrins, Pyrethrum Extract and Piperonyl Butoxide are active ingredients.
ATI 064Information on MA for Cooper Cattle Dip ad Sheep Dip.
ATI 063Information relating to representations made by lobbying groups with regard to Cypermethrin based sheep dips.
ATI 062Request for details of adverse reactions to flea treatments in which Pyrethrins, Pyrethrum Extract and Piperonyl Butoxide are active ingredients.
ATI 061Information relating to VMD properties and leaseholds.
ATI 060Request for information on the evidence leading to the suspension of the Marketing Authorisation for Ecofleece.
ATI 059Further requests in relation to Lelystad (Dutch) tuberculin. Opened as a new ATI as advised by IMD.
ATI 058Information on PSA targets and specific documents relating to IT services.
ATI 057Information concerning imported Lelystad (Dutch) tuberculin for use in the intradermal skin test for detecting bovine TB in cattle.
ATI 056Information relating to the East Cheshire Chemical Company.
ATI 055Correspondence between the VMD and Pfizer relating to the granting of the MAs for Rimadyl Small Animal Injection and Rimadyl Tablets 20, 50 and 1000mg and Financial links between VMD staff and Pfizer or any other pharmaceutical company.
ATI 054Request for detailed information relating to the Marketing Authorisation for Rimadyl Small Animal Injection VM00057/4193 and contra-indications. Contained a request for an internal review on ATI0053 - see above.
ATI 053Information relating to the Marketing Authorisation granted for Rimadyl.
ATI 052Information relating to the approval of applications for Wilko dog flea and tick drops and Canac dog flea drops.
ATI 051Detailed information relating the applications for Marketing Authorisations for cypermethrin sheep dip products.
ATI 050All correspondence, both internal and external, relating to the ban on cypermethrin based sheep dips.
ATI 049Evidence leading to the suspension of the Marketing Authorisation for Ecofleece.
ATI 048Evidence on which the suspension of the Marketing Authorisation for Robust was based.
ATI 047Environmental Risk Assessments for cypermethrin based sheep dips.
ATI 046Information about the manufacturing site addresses for Tylan G20 Premix, Eli Lilly and Company.
ATI 045Narrowed down request for information on the efficacy of and specific criteria used by the UK to approve Rabies vaccines.
ATI 044Request for recent correspondence to enable applicant to ascertain the chain of events in the investigation/prosecution of John Burns of Burns Pet Nutrition Ltd.
ATI 043All correspondence generated as part of ATI0033.
ATI 042Information on the efficacy of rabies vaccines - expert advice and relevant facts in relation to the efficacy of rabies vaccines and the UK's position on vaccines in relation to quarantine rules.
ATI 041Cadmium testing in Norwegian salmon.

2005

ATI No. Subject
ATI 040Formulations containing praziquantel that are authorized in the UK for cat and dog use.
ATI 039Medicinal claims made by Burns Pet Nutrition Ltd and specific information on the number and nature of complaints made to the VMD about pet food companies making medicinal claims about their pet foods.
ATI 038All papers relating to the Defra vs Burns Pet Nutrition Ltd court case.
ATI 037Medicinal claims made by Burns Pet Nutrition and information on complaints made against pet food companies.
ATI 036Information on Founderguard use released in 2001.
ATI 035Study endpoints of the studies on physical-chemical properties, environmental fate and behaviour, ecotoxicology, and analytical methods for soil groundwater and surface water, for the active ingredient lincomycin, for all registered products.
ATI 034Assessment reports prepared by the VMD for all aspects of target animal safety and of preclinical and clinical efficacy, and Expert reports prepared by the company for all aspects of target animal safety and of preclinical and clinical efficacy in respect of Fortekor: VM 12501/4129, Vm 12501/4029 and Vm 12501/4030, held by Novartis Animal Health.
ATI 033Information on environmental risk assessments Novartis' product Robust & Bimeda's product Ecofleece.
ATI 032Request for sight of DCA advice on ATI0020.
ATI 031Request for Staff handbook.
ATI 030Correspondence between the VMD and Joanna Tuffnell/PRI Group between the 27 August 2004 and 15 July 2005, when Joanna Tuffnell/PRI Group was providing consultancy support for Global Genetics application up until the 12 August, when VMD received notification that the arrangement had ended.
ATI 0293rd party complaints about Nestle product.
ATI 028Non-Stat results of testing 3rd country imports.
ATI 027Information relating VMD and vehicle insurance.
ATI 026Results of tests on sheep dip products 1985-2005.
ATI 025Disclosure of the identity of complainants against Biotal.
ATI 024Use of cypermethrin as sheep dip in West Wales.
ATI 023Synthetic pyrethroid sheep dip environmental incidents.
ATI 022Request for a full list of ingredients for Aquaguard Sea Lice Treatment.
ATI 021Request from Norbrook Laboratories for correspondence between Dr. Quinn and the VMD.
ATI 020Use of Founderguard in the UK.
ATI 019The use of cypermethrin as a sheep dip in West Wales.
ATI 018Request covering a range of issues relating to ATI 008.
ATI 017Regarding batches of veterinary immunological products.
ATI 016Requesting information on the court proceedings against Burns Pet Nutrition Ltd.
ATI 015The veterinary poultry salmonella vaccines used in the UK.
ATI 014Relating to pimobendan.
ATI 013Correspondence we hold between Hills Pet Nutrition Ltd and the VMD concerning Hills' Prescription Diet i/d and what changes were requested and made to Hills' promotional literature.
ATI 012Correspondence between VMD and named companies on unauthorised medicinal claims.
ATI 011Presence of streptomycin in tropical honeys, with the purpose of proving that this antibiotic can be naturally occurring in honey.
ATI 010Details of prosecutions taken by the Veterinary Medicines Directorate and / or Defra / MAFF where a product which is deemed to be medicinal has been presented for sale without a marketing Authorisation.
ATI 009Use of cypermethrin as sheep dip in West Wales.
ATI 008Request covering a range of issues.
ATI 007Relating residue surveillance import data.
ATI 006Relating to the unlicensed medicinal claims and marketing of pet foods carried out by Burns Pet Nutrition Ltd.
ATI 005Cost of the Independent Review of Dispensing and the competition commission investigation.
ATI 004The autopsy papers which were obtained from cattle on which organophosphates were tested in the effort to remove the threat of warble fly infestation.
ATI 003Information in relation to the Judicial Review Maff v Norbrook Laboratories Ltd.
ATI 002Review and evaluation of diazinon conducted in the late 90's / early 2000's for re-registration as an ectoparasite control agent (sheep dip).
ATI 001Information about Rimadyl and on the VMD's traffic light document on the release of human and veterinary medicines regulatory information.


Last Updated: 16 September 2013

ISO 27001 Accredited logo Positive about disabled people logo iip logo

The VMD is an executive agency of defra defra logo